Americans for Health Excellence (AFHE) Executive Director Dr. Brad Wenstrup today applauded President Trump’s announcement of nine new Most Favored Nation drug pricing agreements, bringing the total to 26 manufacturers covering 89 percent of the branded drug market. For years, Americans have been asking why their medicines cost less somewhere outside of America.

“For decades, foreign governments used price controls to exploit American innovation while American patients paid the difference. Fortunately, President Trump is closing that gap and making great strides toward ending foreign exploitation, deal by deal, ensuring other countries finally pay their fair share. This is delivering real savings patients can see right now. Americans for Health Excellence supports this work as it coincides well with the progress TrumpRx has already delivered toward greater affordability.”

ABOUT AMERICANS FOR HEALTH EXCELLENCE 

Americans for Health Excellence (AFHE) is a 501(c)(4) health policy organization dedicated to building a healthcare system that puts patients first — lowering costs, expanding access, and ensuring every American has the tools and information to make the best healthcare decisions for themselves and their families. AFHE advances market-based solutions while engaging all in the healthcare system on behalf of patient health.

For more information, visit AmericansforHealthExcellence.org.